100 Recruiting Studies Using Gemcitabine
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Gemcitabine
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer
📍 OHSU Knight Cancer Institute — Portland, Oregon
Pancreatic Adenocarcinoma
View Study & Checklist ➔A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
📍 City of Hope Cancer Center — Duarte, California
Non-Hodgkin Lymphoma
View Study & Checklist ➔Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)
📍 Highlands Oncology Group - Springdale /ID# 270290 — Springdale, Arkansas
Urothelial Carcinoma
View Study & Checklist ➔A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
📍 Indiana University — Indianapolis, Indiana
Carcinoma Breast Stage IV
View Study & Checklist ➔A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
📍 Loma Linda Univ Faculty Medic — Loma Linda, California
Urinary Bladder Neoplasms
View Study & Checklist ➔Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
📍 City of Hope Corona — Corona, California
FIGO Stage IVA Ovarian Cancer
View Study & Checklist ➔Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Stage IB Lung Non-Small Cell Carcinoma AJCC v7
View Study & Checklist ➔A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
📍 UC San Diego Moores Cancer Center — La Jolla, California
Lymphoma
View Study & Checklist ➔A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer
📍 Local Institution - 0022 — Tucson, Arizona
Urinary Bladder Neoplasms
View Study & Checklist ➔Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON).
📍 Research Site — Phoenix, Arizona
Non Small Cell Lung Cancer NSCLC
View Study & Checklist ➔Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
Pancreatic Cancer
View Study & Checklist ➔Intravesical BCG vs GEMDOCE in NMIBC
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Non-muscle-invasive Bladder Cancer
View Study & Checklist ➔A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.
📍 MD Anderson Cancer Center — Houston, Texas
Pancreas Cancer
View Study & Checklist ➔Proglumide and Chemotherapy for Metastatic Pancreatic Cancer
📍 Lombardi Comprehensive Cancer Center, Georgetown University — Washington D.C., District of Columbia
Metastatic Pancreatic Cancer
View Study & Checklist ➔Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Urothelial Carcinoma
View Study & Checklist ➔A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
Solid Tumor
View Study & Checklist ➔Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Mycosis Fungoides
View Study & Checklist ➔A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC
📍 Research Site — Iowa City, Iowa
Metastatic Non-Small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)
📍 Research Site — Anaheim, California
Non Small Cell Lung Carcinoma NSCLC
View Study & Checklist ➔Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Fallopian Tube Clear Cell Adenocarcinoma
View Study & Checklist ➔Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
Lymphoma
View Study & Checklist ➔Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Metastatic Fallopian Tube Carcinoma
View Study & Checklist ➔A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
📍 Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers — Chandler, Arizona
Relapsed/Refractory Diffuse Large B-cell Lymphoma
View Study & Checklist ➔Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder
📍 University of Chicago — Chicago, Illinois
Muscle-invasive Urothelial Cancer of the Bladder
View Study & Checklist ➔Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
📍 Veterans Administration Medical Center - Birmingham — Birmingham, Alabama
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma
View Study & Checklist ➔Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
📍 Arizona Oncology Associates, PC-Hope,1845 W Orange Grove Rd — Tucson, Arizona
Triple Negative Breast Cancer
View Study & Checklist ➔Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Ovarian Serous Tumor
View Study & Checklist ➔Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Pancreatic Adenocarcinoma
View Study & Checklist ➔Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer
📍 Princess Margaret Cancer Centre — Toronto, Ontario
Pancreatic Cancer, Advanced or Metastatic
View Study & Checklist ➔Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
📍 Beverly Hills Cancer Center — Beverly Hills, California
Locally Advanced Breast Cancer
View Study & Checklist ➔GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
📍 Alaska Oncology and Hematology LLC — Anchorage, Alaska
Malignant Solid Tumor
View Study & Checklist ➔A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies
📍 Research Site — Santa Monica, California
Advanced Pancreatic Cancer
View Study & Checklist ➔Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Resectable Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Pancreatic Cancer
View Study & Checklist ➔Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer
📍 Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
Urothelial Carcinoma Bladder
View Study & Checklist ➔A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
📍 City of Hope National Medical Center /ID# 273338 — Duarte, California
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery
📍 City of Hope Medical Center — Duarte, California
Pancreatic Adenocarcinoma
View Study & Checklist ➔A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
📍 University of Alabama at Birmingham — Birmingham, Alabama
Diffuse Large B-cell Lymphoma
View Study & Checklist ➔A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut
Bladder Cancer
View Study & Checklist ➔Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
📍 Research Site — Phoenix, Arizona
Metastatic Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Bladder Urothelial Carcinoma
View Study & Checklist ➔Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
📍 Research Site — La Jolla, California
Locally Advanced or Metastatic Solid Tumours
View Study & Checklist ➔Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
📍 Rocky Mountain Cancer Center — Denver, Colorado
Metastatic Urothelial Cancer
View Study & Checklist ➔Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Metastatic Pancreatic Adenocarcinoma
View Study & Checklist ➔Saltikva for Metastatic Pancreatic Cancer
📍 Segal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial — Montreal, Quebec
Metastatic Pancreatic Cancer
View Study & Checklist ➔First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer
📍 Northwell Health / R.J. Zuckerberg Cancer Center — New Hyde Park, New York
Pancreatic Cancer
View Study & Checklist ➔Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL)
📍 University of Alabama at Birmingham — Birmingham, Alabama
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
📍 St. Joseph Heritage Medical Group — Fullerton, California
Pancreatic Cancer
View Study & Checklist ➔A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
📍 Research Site — Duarte, California
Breast Cancer
View Study & Checklist ➔Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]
📍 Ironwood Cancer & Research Centers - Chandler II — Chandler, Arizona
Breast Cancer
View Study & Checklist ➔Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer
📍 Ironwood Cancer & Research Centers - Chandler — Chandler, Arizona
Urothelial Cancer
View Study & Checklist ➔Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Bladder Urothelial Carcinoma
View Study & Checklist ➔AGEN1423 and Botensilimab w/ or w/o Chemo in PDAC
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
Advanced Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Ovarian Brenner Tumor
View Study & Checklist ➔A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung Cancer
📍 Rush University Medical Center — Chicago, Illinois
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)
📍 Mayo Clinic in Arizona - Phoenix — Phoenix, Arizona
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Focused Ultrasound and Gemcitabine in Breast Cancer
📍 University of Virginia — Charlottesville, Virginia
Breast Cancer
View Study & Checklist ➔A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer
📍 Sutter Auburn Faith Hospital — Auburn, California
Combined Hepatocellular Carcinoma and Cholangiocarcinoma
View Study & Checklist ➔Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
📍 Mayo Clinic of Scottsdale — Phoenix, Arizona
Cholangiocarcinoma
View Study & Checklist ➔Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)
📍 Research Site — Anaheim, California
Non Small Cell Lung Carcinoma NSCLC
View Study & Checklist ➔Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
📍 Research Site — Birmingham, Alabama
Biliary Tract Cancer
View Study & Checklist ➔Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
📍 Alaska Oncology and Hematology — Anchorage, Alaska
Triple Negative Breast Cancer
View Study & Checklist ➔A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
📍 Ambulatory Care Center — New York, New York
Pancreatic Cancer
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors
📍 National Cancer Institute Developmental Therapeutics Clinic — Bethesda, Maryland
Advanced Fallopian Tube Carcinoma
View Study & Checklist ➔Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
Solid Tumor
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
📍 UC Davis — Sacramento, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
📍 Banner MD Anderson — Gilbert, Arizona
Advanced Cancer
View Study & Checklist ➔Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
📍 Fairbanks Memorial Hospital — Fairbanks, Alaska
Infiltrating Bladder Urothelial Carcinoma
View Study & Checklist ➔A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
📍 Princess Margaret Cancer Centre — Toronto, Ontario
Biliary Tract Carcinoma
View Study & Checklist ➔Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
📍 Alaska Women's Cancer Care — Anchorage, Alaska
Platinum-resistant Ovarian Cancer
View Study & Checklist ➔Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
📍 Research Site — Los Angeles, California
Urothelial Cancer
View Study & Checklist ➔A Study of LY3200882 in Participants With Solid Tumors
📍 University of Louisville — Louisville, Kentucky
Solid Tumor
View Study & Checklist ➔Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
📍 Research Site — Birmingham, Alabama
Hepatocellular Carcinoma
View Study & Checklist ➔1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma
📍 University of Maryland Medical Center — Baltimore, Maryland
Advanced Pancreatic Cancer
View Study & Checklist ➔Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
📍 University of Arizona — Tucson, Arizona
Pancreas Cancer
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer
📍 Keck Medicine of USC Koreatown — Los Angeles, California
Lung Non-Small Cell Squamous Carcinoma
View Study & Checklist ➔A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
📍 The University of Arizona Cancer Center — Tucson, Arizona
Biliary Tract Cancer
View Study & Checklist ➔Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Borderline Resectable Pancreatic Adenocarcinoma
View Study & Checklist ➔A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
📍 University of Chicago — Chicago, Illinois
Urothelial Carcinoma
View Study & Checklist ➔A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
📍 Research Site — Phoenix, Arizona
Non-Small Cell Lung Cancer
View Study & Checklist ➔Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
📍 BCCA - Vancouver — Vancouver, British Columbia
Lymphoma, B-Cell
View Study & Checklist ➔A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
📍 Hospital Aleman — Ciudad Autonoma de Buenos Aires, Buenos Aires
B-Cell Non-Hodgkin Lymphoma (B-NHL)
View Study & Checklist ➔Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
📍 Chan Soon-Shiong Institute for Medicine — El Segundo, California
Pancreatic Cancer
View Study & Checklist ➔Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer
📍 Levine Cancer Institute — Charlotte, North Carolina
Metastatic Triple-Negative Breast Cancer
View Study & Checklist ➔Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
📍 Children's Hospital of Alabama — Birmingham, Alabama
Childhood Hepatocellular Carcinoma
View Study & Checklist ➔Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)
📍 Research Site — Mobile, Alabama
Biliary Tract Cancer
View Study & Checklist ➔Intravesical Gem/Doce in Patients With NMIBC
📍 University of Arizona Cancer Center — Tucson, Arizona
Urinary Bladder Cancer
View Study & Checklist ➔9-ING-41 in Patients With Advanced Cancers
📍 Mayo Clinic — Phoenix, Arizona
Cancer
View Study & Checklist ➔A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
📍 Comprehensive Blood and Cancer Center — Bakersfield, California
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
View Study & Checklist ➔Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
📍 Sidney Kimmel Cancer Center at Thomas Jefferson University — Philadelphia, Pennsylvania
Locally Advanced Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer
📍 Kingman Regional Medical Center — Kingman, Arizona
Metastatic Bladder Urothelial Carcinoma
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Bladder Flat Urothelial Carcinoma In Situ
View Study & Checklist ➔Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)
📍 Research Site — Bonita Springs, Florida
Non-small Cell Lung Cancer NSCLC
View Study & Checklist ➔A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
📍 Highlands Oncology Group, PA — Fayetteville, Arkansas
Carcinoma, Pancreatic Ductal
View Study & Checklist ➔A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
📍 Lucille Packard Children's Hospital at Stanford University Medical Center — Palo Alto, California
Medulloblastoma
View Study & Checklist ➔The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Pancreatic Acinar Cell Carcinoma
View Study & Checklist ➔A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)
📍 Arkansas Urology — Little Rock, Arkansas
Non-Muscle Invasive Bladder Neoplasms
View Study & Checklist ➔GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Adult Solid Neoplasm
View Study & Checklist ➔Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder
📍 Columbia University Irving Medical Center - HIP — New York, New York
Urothelial Carcinoma of the Urinary Bladder
View Study & Checklist ➔Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer
📍 Local Institution - 0001 — Anchorage, Alaska
Urothelial Cancer
View Study & Checklist ➔